Kite Pharma, Inc. is a company focused on cell therapy to treat and potentially cure cancer. As a subsidiary of Gilead Company, Kite Pharma is dedicated to changing the way cancer is treated. With a strong emphasis on research and development, they are committed to advancing the science of cell therapy and bringing innovative cancer treatments to the market.

Astrid McLean ; Kite Pharma, Inc, profile picture · Kite Pharma, Inc. Sr. Director ; Kite Pharma, profile picture · Kite Pharma. Director, Quality Assurance. May ...

FDA approved axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) for adult patients with large B-cell lymphoma refractory to 1st line ...

Kite Pharma | 127729 followers on LinkedIn. At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer.

Kite Pharma, Inc.

Find contacts at this company